WO2007143131A3 - Formulations de sel de prédnisolone - Google Patents

Formulations de sel de prédnisolone Download PDF

Info

Publication number
WO2007143131A3
WO2007143131A3 PCT/US2007/013008 US2007013008W WO2007143131A3 WO 2007143131 A3 WO2007143131 A3 WO 2007143131A3 US 2007013008 W US2007013008 W US 2007013008W WO 2007143131 A3 WO2007143131 A3 WO 2007143131A3
Authority
WO
WIPO (PCT)
Prior art keywords
tablets
sodium phosphate
prednisolone sodium
phosphate formulations
odts
Prior art date
Application number
PCT/US2007/013008
Other languages
English (en)
Other versions
WO2007143131A9 (fr
WO2007143131A2 (fr
Inventor
Walid Habib
Bhaveshkumar Kothari
Original Assignee
Cima Labs Inc
Walid Habib
Bhaveshkumar Kothari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/638,216 external-priority patent/US8637076B2/en
Priority claimed from US11/638,260 external-priority patent/US20070281014A1/en
Application filed by Cima Labs Inc, Walid Habib, Bhaveshkumar Kothari filed Critical Cima Labs Inc
Priority to MX2008015059A priority Critical patent/MX2008015059A/es
Priority to CA002653485A priority patent/CA2653485A1/fr
Publication of WO2007143131A2 publication Critical patent/WO2007143131A2/fr
Publication of WO2007143131A9 publication Critical patent/WO2007143131A9/fr
Publication of WO2007143131A3 publication Critical patent/WO2007143131A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Abstract

La présente invention concerne des comprimés contenant des sels de prédnisolone et en particulier des phosphates de sodium de prédnisolone. Les comprimés comprennent des comprimés effervescents ODT et non-ODT et des comprimés non effervescents et des comprimés satisfaisant à certains critères de performance.
PCT/US2007/013008 2006-06-01 2007-05-30 Formulations de sel de prédnisolone WO2007143131A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2008015059A MX2008015059A (es) 2006-06-01 2007-05-30 Formulaciones de sal prednisolona.
CA002653485A CA2653485A1 (fr) 2006-06-01 2007-05-30 Formulations de sel de prednisolone

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US81001506P 2006-06-01 2006-06-01
US60/810,015 2006-06-01
US11/638,216 US8637076B2 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
US11/638,260 US20070281014A1 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
US11/638,260 2006-12-13
US11/638,216 2006-12-13

Publications (3)

Publication Number Publication Date
WO2007143131A2 WO2007143131A2 (fr) 2007-12-13
WO2007143131A9 WO2007143131A9 (fr) 2008-02-14
WO2007143131A3 true WO2007143131A3 (fr) 2008-03-20

Family

ID=38616310

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2007/013008 WO2007143131A2 (fr) 2006-06-01 2007-05-30 Formulations de sel de prédnisolone
PCT/US2007/012883 WO2007143061A2 (fr) 2006-06-01 2007-05-31 Formules de sels de prednisolone

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2007/012883 WO2007143061A2 (fr) 2006-06-01 2007-05-31 Formules de sels de prednisolone

Country Status (3)

Country Link
CA (2) CA2653485A1 (fr)
MX (2) MX2008015059A (fr)
WO (2) WO2007143131A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926722B1 (fr) * 2008-01-25 2010-09-03 Substipharm Dev Formulation pharmaceutique appropriee pour la preparation de comprimes orodispersibles de prednisolone

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615854A (fr) *
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
WO2000030617A1 (fr) * 1998-11-25 2000-06-02 Cima Labs Inc. Systeme d'enrobage a liberation rapide masquant le gout
WO2003053415A1 (fr) * 2001-12-20 2003-07-03 Alpex Pharma Sa Composition pharmaceutique comprenant de la poudre de lait ecreme
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
WO2004060354A1 (fr) * 2002-12-31 2004-07-22 Augsburger Larry L Procede pour la fabrication de formes posologiques de produits pharmaceutiques contenant des composants agissant comme un rembourrage protecteur
US20050287211A1 (en) * 2004-04-30 2005-12-29 Astellas Pharma Inc. Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615854A (fr) *
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
WO2000030617A1 (fr) * 1998-11-25 2000-06-02 Cima Labs Inc. Systeme d'enrobage a liberation rapide masquant le gout
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
WO2003053415A1 (fr) * 2001-12-20 2003-07-03 Alpex Pharma Sa Composition pharmaceutique comprenant de la poudre de lait ecreme
WO2004060354A1 (fr) * 2002-12-31 2004-07-22 Augsburger Larry L Procede pour la fabrication de formes posologiques de produits pharmaceutiques contenant des composants agissant comme un rembourrage protecteur
US20050287211A1 (en) * 2004-04-30 2005-12-29 Astellas Pharma Inc. Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "BioMarin Announces U.S. FDA Acceptance of Orapred ODT Filing", NEW DRUG APPLICATIONS, 19 October 2005 (2005-10-19), XP002462634, Retrieved from the Internet <URL:http://www.drugs.com/nda/orapred_odt_051019.html> [retrieved on 20071217] *
BERTHOLD A ET AL: "Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 39, no. 1, March 1996 (1996-03-01), pages 17 - 25, XP004037383, ISSN: 0168-3659 *

Also Published As

Publication number Publication date
MX2008015058A (es) 2009-04-14
WO2007143131A9 (fr) 2008-02-14
CA2653485A1 (fr) 2007-12-13
CA2653480A1 (fr) 2007-12-13
WO2007143061A2 (fr) 2007-12-13
WO2007143131A2 (fr) 2007-12-13
MX2008015059A (es) 2009-04-14
WO2007143061A3 (fr) 2008-02-14

Similar Documents

Publication Publication Date Title
WO2007064885A3 (fr) Compositions, procedes, dispositifs et systemes pour soins buccaux
HUP0600027A2 (en) Antiseptic compositions, methods and systems
WO2008151273A3 (fr) Systèmes de parfum
GB0415219D0 (en) Improvements in or relating to time-of-flight ranging systems
WO2006131591A3 (fr) Forme posologique destinee a etre administree par voie orale
WO2010002586A3 (fr) Compositions topiques contenant de l’isonicotinamide
EP3067410A3 (fr) Compositions de nettoyage
WO2008073483A3 (fr) Procédés et systèmes liés à la réception d&#39;information associée à des nutraceutiques
WO2010030598A3 (fr) Formulations pharmaceutiques comprenant du pemetrexed
WO2007106436A3 (fr) Composes et compositions photoactifs et utilisations derivees
BRPI0506779A (pt) formulação de sorvete, e, sorvete
WO2007021730A3 (fr) Formulations destinees a la tenue des cheveux
WO2007124102A3 (fr) Préparation et utilisation de compositions contenant de la phlorizine
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
EP1916251A4 (fr) Sels d érianine, leurs procédés de préparation et compositions pharmaceutiques contenant ceux-ci
WO2008142569A3 (fr) Compositions topiques contenant du magaldrate
WO2007144521A3 (fr) Composition cosmetique a usage topique comprenant du wasabi
WO2007029087A3 (fr) Preparations multi-unites a liberation controlee
WO2008073863A3 (fr) Préparation et utilité d&#39;allylamines substituées
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
WO2007083190A8 (fr) Extrait d&#39;helychrisum insoluble dans l&#39;eau, et procédés d&#39;élaboration et d&#39;utilisation correspondants
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2004073686A3 (fr) Solutions de medicaments dans du menthol
WO2007098924A3 (fr) Composition stabilisant l&#39;eau, procede de production et d&#39;utilisation associes
WO2007143131A3 (fr) Formulations de sel de prédnisolone

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2653485

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2008/015059

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07795639

Country of ref document: EP

Kind code of ref document: A2